Click Chemistry Enters Clinical Trials

Dr. Maksim Royzen, associate professor of Chemistry and RNA Institute Faculty member, has partnered with Shasqi to develop a click chemistry compound designed to target a powerful cancer drug at tumor cells while sparing healthy ones. This is the first time that click chemistry has been used inside a patient’s body. The treatment has just entered Phase 1 clinical trials. Read full article in Chemical & Engineering News.